FDA Grants De Novo Classification to TytoCare’s AI Otoscopy Tool
The AI-driven software analyzes otoscopy videos to detect eardrum bulging, establishing a new regulatory category for ENT diagnostic aids.
Category: Vestibular Solutions
Vestibular Solutions
Latest
Vestibular Solutions
Latest
Heuser Hearing Institute Director Publishes Research Related to Post-traumatic Dizziness
The objectives of this study were to describe a potentially underappreciated pathology for post-traumatic persistent intractable dizziness and third window syndrome as well as the methods to diagnose and surgically manage this disorder.
Vestibular Solutions
Latest
CILcare Partners with Vertidiag on Vestibular Solutions
Vertidiag is said to have developed a technical platform to induce controlled vestibular disorders and to measure their functional impacts. This platform uses behavioral pharmacology, along with a battery of cellular and molecular biology tools that support the understanding of the mechanisms of action of potential drug candidates.
Diagnostic Equipment
Latest
Anders Hedegaard Resigns as CEO of GN Hearing
GN Hearing CEO Anders Hedegaard has resigned after accepting a position as CEO in another company outside of the hearing industry. Marcus Desimoni will act as interim CEO of GN Hearing, in parallel with his role as CFO of GN Store Nord and GN Hearing, until a new CEO for GN Hearing is appointed.
Rehab & Therapeutics
Latest
Frequency Therapeutics Announces Hearing Loss Drug Has FDA Fast-Track Designation
In a Phase 1/2 study, FX-322 demonstrated a statistically significant and clinically meaningful improvement in key measures of hearing loss, including clarity of sound and word recognition, with no serious adverse events observed.